Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The control gel is a topical vehicle formulation developed by the State University of Maringá (Universidade Estadual de Maringá) for use as a placebo comparator in clinical trials. Specifically, it was utilized in a randomized, double-blind study evaluating the safety and efficacy of insulin-based gels for the treatment of Grade II pressure ulcers in intensive care unit (ICU) patients. The formulation consists of a Carbopol 940® polymer base, purified water, propylene glycol, and preservatives (methylparaben and propylparaben), with the pH adjusted using triethanolamine. While designed as an inactive control to isolate the effects of active ingredients like insulin or insulin-cyclodextrin complexes, the gel provides a moist environment and protective barrier that may support tissue revitalization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on control gel-State University of Maringá-pressure ulcer.